HK1046363B - 含有抗生素和nsaid的眼用組合物 - Google Patents

含有抗生素和nsaid的眼用組合物

Info

Publication number
HK1046363B
HK1046363B HK02107658.6A HK02107658A HK1046363B HK 1046363 B HK1046363 B HK 1046363B HK 02107658 A HK02107658 A HK 02107658A HK 1046363 B HK1046363 B HK 1046363B
Authority
HK
Hong Kong
Prior art keywords
component
composition
nsaids
compositions containing
ophthalmic compositions
Prior art date
Application number
HK02107658.6A
Other languages
English (en)
Other versions
HK1046363A1 (en
Inventor
Christopher A Muller
Elizabeth A Bancroft
Janet K Cheetham
Harold G Jensen
Teresa H Kuan
David F Power
Kevin D Skule
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/365,291 external-priority patent/US6166012A/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HK1046363A1 publication Critical patent/HK1046363A1/xx
Publication of HK1046363B publication Critical patent/HK1046363B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02107658.6A 1999-07-30 2002-10-22 含有抗生素和nsaid的眼用組合物 HK1046363B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36433499A 1999-07-30 1999-07-30
US09/365,291 US6166012A (en) 1999-07-30 1999-07-30 Antibiotic compositions and method for using same
PCT/US2000/020579 WO2001008689A1 (en) 1999-07-30 2000-07-28 Ophthalmic compositions containing antibiotics and nsaids

Publications (2)

Publication Number Publication Date
HK1046363A1 HK1046363A1 (en) 2003-01-10
HK1046363B true HK1046363B (zh) 2006-12-08

Family

ID=27002428

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107658.6A HK1046363B (zh) 1999-07-30 2002-10-22 含有抗生素和nsaid的眼用組合物

Country Status (10)

Country Link
US (4) US6552020B1 (zh)
EP (2) EP1200094B1 (zh)
JP (1) JP2003505511A (zh)
AT (1) ATE330609T1 (zh)
AU (1) AU777245B2 (zh)
CA (1) CA2388297A1 (zh)
DE (1) DE60028978T2 (zh)
ES (1) ES2261223T3 (zh)
HK (1) HK1046363B (zh)
WO (1) WO2001008689A1 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20050009836A1 (en) * 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
EP1981491A4 (en) * 2006-01-25 2009-09-23 Aciex Inc COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DROUGHT
WO2008085913A1 (en) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
CA2687717A1 (en) * 2007-05-24 2008-12-18 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
WO2009007409A2 (en) * 2007-07-09 2009-01-15 Novagali Pharma Sa Oil in water emulsion comprising nsaids and quaternary ammonium halides
EP2016936B1 (en) * 2007-07-09 2010-09-15 Novagali Pharma S.A. Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
US8512687B2 (en) 2007-07-09 2013-08-20 Novagali Pharma Sa Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
JP2011520963A (ja) * 2008-05-19 2011-07-21 アルコン リサーチ， リミテッド カルボキシビニルポリマーおよびポビドンポリマーを有する医薬組成物
US8778999B2 (en) * 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2013055856A1 (en) * 2011-10-12 2013-04-18 Bausch & Lomb Incorporated Ocular composition containing bromfenac with increased bioavailability
AU2014252808A1 (en) * 2013-04-09 2015-11-12 Cresset Biomolecular Discovery Ltd The treatment of inflammatory disorders
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
CN103432069A (zh) * 2013-09-12 2013-12-11 安徽环球药业股份有限公司 不含抑菌剂的氧氟沙星滴眼液及其制备方法
US20150335704A1 (en) 2014-05-23 2015-11-26 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions comprising gels and methods for fabricating thereof
EP3302382A4 (en) * 2015-05-29 2019-02-20 Allergan, Inc. IMPLANT FOR THE TREATMENT OF OCULAR DISEASE
CN105534886A (zh) * 2015-12-31 2016-05-04 湖北远大天天明制药有限公司 一种诺氟沙星滴眼剂及其制备方法
MX2020000265A (es) 2017-07-07 2020-07-22 Epicentrx Inc Composiciones para la administración parenteral de agentes terapéuticos.
IT202000026690A1 (it) * 2020-11-09 2022-05-09 Ntc S R L Composizione oftalmica contenente levofloxacina e ketorolac, metodo di preparazione e suo utilizzo

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4454151A (en) 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US4551456A (en) 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
US5414011A (en) 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US5110493A (en) 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5360611A (en) 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
ES2065846B1 (es) 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
JP2742333B2 (ja) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるビタミンｅトコフェリル誘導体の使用
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6166012A (en) 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
JP4500261B2 (ja) * 2003-01-21 2010-07-14 千寿製薬株式会社 ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性液剤

Also Published As

Publication number Publication date
US20030114464A1 (en) 2003-06-19
AU777245B2 (en) 2004-10-07
DE60028978T2 (de) 2007-02-22
EP1200094A1 (en) 2002-05-02
HK1046363A1 (en) 2003-01-10
US6552020B1 (en) 2003-04-22
US6548497B2 (en) 2003-04-15
ATE330609T1 (de) 2006-07-15
AU6498500A (en) 2001-02-19
US20010034353A1 (en) 2001-10-25
WO2001008689A1 (en) 2001-02-08
EP1200094B1 (en) 2006-06-21
DE60028978D1 (de) 2006-08-03
CA2388297A1 (en) 2001-02-08
US20080070908A1 (en) 2008-03-20
ES2261223T3 (es) 2006-11-16
JP2003505511A (ja) 2003-02-12
EP1688144A1 (en) 2006-08-09

Similar Documents

Publication Publication Date Title
HK1046363B (zh) 含有抗生素和nsaid的眼用組合物
AU2001239725A1 (en) Antibacterial agents
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
CA2299227A1 (en) Synergistic biocide composition
AU3196295A (en) Dioxide-containing compositions for use in the eye
AU3806400A (en) Engine oil composition with reduced deposit-formation tendency
AU2001286441A1 (en) Composition exhibiting synergistic antioxidant activity
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
EP0987321A3 (en) Ultramild antibacterial cleaning composition for frequent use
AU6795600A (en) Gums containing antimicrobial agents
AU5920999A (en) Pesticidal compositions containing essential oils with enzyme inhibitors
PL352382A1 (en) Ophthalmic composition containing ketotifene
WO1998049999A3 (en) Antimicrobial compositions for topical use
AU628645B2 (en) Agent for preventing infection with antibiotic-resistant staphylococcus
AU2147095A (en) Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
AU2118801A (en) Thiadizole dimer additives and lubricating compositions containing the same
AU642753B2 (en) Halogen-containing compounds, herbicidal composition containing the same as an active ingredient, and intermediary compounds therefor
TW354762B (en) Agent for prophylaxis or treatment of cataract
AU5303399A (en) Refrigerating machine oil composition
AU5464300A (en) High refractive index compositions for ophthalmic implants
AU2001238131A1 (en) Polymer compositions useful as dye complexing agents, and processes for preparing same
EP0760363A4 (en) 2- (SUBSTITUTED PHENYL) -2-ALKOXYIMINO-N-ALKYL ACETAMIDES AND BACTERICIDES CONTAINING THEM
AU4835300A (en) Silane copolymer compositions containing active agents
WO2001012607A3 (fr) Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120728